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Chemistry and Health of Olive
Oil Phenolics
SARA CICERALE,1 XAVIER A. CONLAN,2 ANDREW J. SINCLAIR,1
and RUSSELL S. J. KEAST1
1School of Exercise and Nutrition Sciences, Deakin University, Victoria, Australia
2Institute of Biochemistry (Bio Deakin), Deakin University, Victoria, Australia
The Mediterranean diet is associated with a lower incidence of atherosclerosis, cardiovascular disease, and certain types
of cancer. The apparent health benefits have been partially attributed to the dietary consumption of virgin olive oil by
Mediterranean populations. Most recent interest has focused on the biologically active phenolic compounds naturally present
in virgin olive oils. Studies (human, animal, in vivo and in vitro) have shown that olive oil phenolics have positive effects
on certain physiological parameters, such as plasma lipoproteins, oxidative damage, inflammatory markers, platelet and
cellular function, and antimicrobial activity. Presumably, regular dietary consumption of virgin olive oil containing phenolic
compounds manifests in health benefits associated with a Mediterranean diet. This paper summarizes current knowledge on
the physiological effects of olive oil phenolics. Moreover, a number of factors have the ability to affect phenolic concentrations
in virgin olive oil, so it is of great importance to understand these factors in order to preserve the essential health promoting
benefits of olive oil phenolic compounds.
Keywords Virgin olive oil, olive oil phenolics, Mediterranean diet, health benefits
INTRODUCTION
The Mediterranean diet is associated with reduced risk of
morbidity (particularly atherosclerosis, cardiovascular disease,
and certain types of cancer) and mortality (de Lorgeril et al.,
1999; Fortes et al., 2003; Grasso et al., 2006; Herrera et al., 2001;
Matalas et al., 2001; Singh et al., 2002; Stark and Madar, 2002;
Trichopoulou et al., 2003; Visioli and Galli, 1995) and this has
partially been explained by the consumption of virgin olive oil
(Filik and Ozyilkan, 2003; Hu, 2003; Kok and Kromhout, 2004;
Kris-Etherton et al., 2001; Kushi et al., 1995; Matalas et al.,
2001; Stark and Madar, 2002; Visioli and Galli, 1995; Willett
et al., 1995). Virgin olive oil is produced from the first and sec-
ond pressings of the olive fruit by the cold-pressing method,
where no chemicals and only a small amount of heat are ap-
plied. This virgin olive oil is composed of a glycerol fraction
(making up 90–99% of the olive fruit) and a non-glycerol or
unsaponifiable fraction (making up 0.4–5% of the olive fruit)
(Tripoli et al., 2005). Olive oil consists of the inferior oil that
is a result of subsequent pressings after the virgin oil has been
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tion Sciences, Deakin University 221 Burwood Highway, Burwood, Victoria
3125 Australia. Phone: 03 92446944, International: +61 3 92446944, Fax: 03
92446017. E-mail: russell.keast@deakin.edu.au
extracted from lower-quality olives. This oil then undergoes a
refining process involving heat and chemical solvents. Olive oil
contains little to no unsaponifiable compounds. Historically, the
healthful properties of virgin olive oil were attributed to a high
proportion of monounsaturated fatty acids (MUFAs), namely
oleic acid, which represents 70–80% of the fatty acids present
in virgin olive oil (Tripoli et al., 2005). However, several seed
oils (including sunflower, soybean, and rapeseed) rich in MUFA
have been demonstrated to be ineffective in beneficially alter-
ing chronic disease risk factors (Aguilera et al., 2004; Harper
et al., 2006). In addition to MUFA, virgin olive oil contains a
minor, yet significant phenolic component that other seed oils
lack. Thus, the phenolic fraction of virgin olive oil has generated
much interest regarding its health promoting properties. Subse-
quent studies (human, animal, in vivo and in vitro) have demon-
strated that olive oil phenolics have positive effects on certain
physiological parameters, possibly reducing the risk of chronic
disease development (Boskou et al., 2006; Carluccio et al., 2003;
Covas et al., 2006b; Martin-Moreno et al., 1994; Nicolaiew et al.,
1998; Psaltopoulou et al., 2004; Stark and Madar, 2002; Visioli
and Galli, 1995; Visioli and Galli, 2002). Moreover, olive oil
phenolics are highly bioavailable, further supporting the puta-
tive health promoting effects of olive oil phenolics (Bai et al.,
1998; Miro Casas et al., 2001; Miro-Casas et al., 2003; Tuck
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CHEMISTRY AND HEALTH OF OLIVE OIL PHENOLICS 219
et al., 2001; Tuck and Hayball, 2002; Visioli et al., 2000a;
Visioli et al., 2000b; Vissers et al., 2002).
There are at least thirty-six structurally distinct phenolics
that have been identified in virgin olive oil. Not all phenolics
are present in every virgin olive oil and there is variation in the
phenolic concentration between virgin olive oils. Such variation
in the phenolic fraction among virgin olive oils is partially a
result of an array of production factors including: variety of the
olive fruit (Bruni et al., 1994; Caravaca et al., 2005; Carrasco
Pancorbo et al., 2004; Cerretani et al., 2005; Esti et al., 1998;
Franconi et al., 2006; Gomez-Alonzo et al., 2002; Sivakumar
et al., 2005; Vinha et al., 2005), region in which the olive fruit
is grown (Vinha et al., 2005), agricultural techniques used to
cultivate the olive fruit (Bruni et al., 1994; Gomez-Rico et al.,
2006; Romero et al., 2002), maturity of the olive fruit at harvest
(Brenes et al., 1999; Esti et al., 1998; Gimeno et al., 2002a;
Gomez-Rico et al., 2006; Kalua et al., 2005; Sivakumar et al.,
2005; Tovar et al., 2001), and olive oil extraction, processing,
and storage methods (Brenes et al., 2001; Cerretani et al., 2005;
Di Giovacchino et al., 2002; Fregapane et al., 2006; Gimeno
et al., 2002a; Gutierrez and Fernandez, 2002; Kalua et al., 2006;
Mailer and Ayton, 2004; Okogeri and Tasioula-Margari, 2002;
Ranalli et al., 1999; Rastrelli et al., 2002). Cooking methods
have also been shown to alter phenolic concentrations in virgin
olive oil (Brenes et al., 2002; Gomez-Alonso et al., 2003). It is
also prudent to note that the analytical method used to quantify
the concentration of phenolics present in virgin olive oil has
an influence on the reported concentration (Carrasco-Pancorbo
et al., 2005). The aim of this paper is to identify the factors that
have a marked effect on phenolic composition and concentration,
as this knowledge will aid in the preservation of these health
promoting compounds.
OLIVE OIL PHENOLICS
There are at least thirty-six structurally distinct olive oil phe-
nolics that have been identified (Table 1). They can be grouped
according to their similar chemical structure in the following
groups:
• Phenolic acids- These compounds can be divided into three
subgroups; benzoic acid derivatives, cinnamic acid deriva-
tives, and other phenolic acids and derivatives. Phenolic acids
have the basic chemical structure of C6–C1 for benzoic acids
and C6–C3 for cinnamic acids (Carrasco-Pancorbo et al.,
2005).
• Phenolic alcohols- These compounds possess a hydroxyl
group attached to an aromatic hydrocarbon group.
• Secoiridoids- This phenolic group is characterized by the pres-
ence of either elenolic acid or elenolic acid derivatives in their
molecular structure (Carrasco-Pancorbo et al., 2005).
• Hydroxy-isocromans- These phenolics are, 3,4-dihydro-1H-
benzo[c]pyran derivatives mainly naturally occurring in na-
ture as part of a complex fused ring system (Bianco et al.,
2001).
• Flavonoids- These polyphenolic compounds contain two ben-
zene rings joined by a linear three carbon chain. They can be
further divided into two subgroups; flavones and flavanols.
• Lignans- The exact structure of this type of phenolic is not
well understood but is based on the condensation of aromatic
aldehydes (Coultate, 2002).
COMPOSITION AND CONCENTRATION OF
PHENOLICS IN VIRGIN OLIVE OIL AND FACTORS
AFFECTING THEIR CONCENTRATION
There is much variation in the composition and concentration
of phenolic compounds among virgin olive oils (Gimeno et al.,
2002a). The range of phenolic concentration in virgin olive oil
means a comparison between studies and this is at best, diffi-
cult (0.02 to 600 mg/kg, Table 1) (Baccouri et al., 2007; Tripoli
et al., 2005). These discrepancies are partly explained by mul-
tiple factors that have the ability to modify the concentrations
of phenolics in virgin olive oil (Carrasco-Pancorbo et al., 2005).
These are discussed in the sections to follow. In order to aid
in preserving the concentrations of phenolics in virgin olive oil
and maximize the chance of the general population acquiring
the health benefits associated with them, it is essential that the
factors affecting the composition and concentration of olive oil
phenolics are identified.
Cultivar and Region of Growth
Cultivar and geographic region are important factors with
regards to phenolic composition and concentration (Cerretani
et al., 2005; Gomez-Alonzo et al., 2002; Vinha et al., 2005).
Gomez-Alonzo and colleagues (Gomez-Alonzo et al., 2002)
demonstrated that the concentrations of a number of phenolic
compounds varied significantly among differing Spanish virgin
olive oil varieties. For instance, the total phenolic content of
the four virgin olive oil varieties examined in the study were
as follows: Arbequina- 25.5 ± 1.85 mg/kg, Hojiblanca 33.6 ±
3.14 mg/kg, Picual- 37.9 ± 4.64 mg/kg, and Cornicabra- 39.2 ±
1.80 mg/kg. Virgin olive oils from different cultivars have also
been found to possess characteristic phenolic profiles. For exam-
ple, the olive oil variety, Santulhana was found to contain a high
amount of luteolin, Lentisca was found to contain a high concen-
tration of hydroxytyrosol and oleuropein, and Madural Fina was
found to contain a high hydroxytyrosol/oleuropein ratio (Vinha
et al., 2005). In relation to geographical region, Vinha and col-
leagues (Vinha et al., 2005) demonstrated that virgin olive oils
obtained from different cultivars but from the same geographical
region had a similar phenolic profile.
Agricultural Techniques used to Cultivate Olive Fruit
The concentrations of phenolics is affected by agricultural
techniques such as irrigation used in the cultivation of olive fruit
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Table 1 Concentrations of the different classes of phenolics present in virgin olive oil.
Name of compound Structure
Quantity in extra
virgin and virgin
olive oil (mg/kg)
Quantity in
refined olive
oil (mg/kg) Reference(s)
Phenolic acids-
Benzoic acid derivatives
Benzoic acid NA NA (Carrasco-Pancorbo et al., 2005)
Gallic acid 0.1–1.4 NA (Carrasco Pancorbo et al., 2004; Coni
et al., 2000)
Gentistic acid 0.3–1.5 NA (Carrasco Pancorbo et al., 2004)
p-Hydroxybenzoic acid/
4-Hydroxybenzoic acid
NQ NA (Carrasco Pancorbo et al., 2004)
Protocatechuic acid/
3,4-Dihydroxybezoic acid
0.03–1.8 NA (Carrasco Pancorbo et al., 2004; Coni
et al., 2000)
Syringic acid NA NA (Carrasco-Pancorbo et al., 2005)
Vanillic acid/ 4-hydroxy-3-methoxy
phenylacetic acid
0.2–0.4 NA (Carrasco Pancorbo et al., 2004; De
Stefano et al., 1999)
Cinnamic acid derivatives
Caffeic acid NQ, 0.04–0.2 NA (Carrasco Pancorbo et al., 2004; Coni
et al., 2000; De Stefano et al.,
1999)
Cinnamic acid NA NA (Carrasco-Pancorbo et al., 2005)
(Continued on next page)
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Table 1 Concentrations of the different classes of phenolics present in virgin olive oil. (Continued)
Name of compound Structure
Quantity in extra
virgin and virgin
olive oil (mg/kg)
Quantity in
refined olive
oil (mg/kg) Reference(s)
o-Coumaric acid NQ, 0.07–0.1 NA (Carrasco Pancorbo et al., 2004; Coni
et al., 2000)
p-Coumaric acid/4-Coumaric acid NQ, 0.1–0.4 NA (Carrasco Pancorbo et al., 2004; Coni
et al., 2000)
Ferulic acid 0.02–0.4 NA (Carrasco Pancorbo et al., 2004; Coni
et al., 2000; Gomez-Alonzo et al.,
2002)
Sinapic acid/Sinapinic acid/3,5-
Dimethoxy-4-hydroxycinnamic
acid/ 4-Hydroxy-3,5-
dimethoxycinnamic
acid/3-(4-hydroxy-3,5-
dimethoxyphenyl) prop-2-enoic
acid
0.4 NA (Carrasco Pancorbo et al., 2004)
Other phenolic acids and derivatives
4-(Acetoxy-ethyl)-1,
2-dihydroxybenzene
NA NA (Carrasco-Pancorbo et al., 2005)
DOPAC/3,4-dihydroxyphenylacetic
acid/4-hydroxyphenylacetic acid
NQ, 0.07 NA (Carrasco Pancorbo et al., 2004)
Phenolic alcohols
Hydroxytyrosol/
2-(3,4-Dihydroxyphenyl) ethanol/
3,4-DHPEA
0.5–14.4 1.7 (Owen et al., 2000a; Selvaggini et al.,
2006; Owen et al., 2000b; Salvini
et al., 2006; Coni et al., 2000; De
Stefano et al., 1999; Gill et al.,
2005; Gomez-Alonso et al., 2003;
Gomez-Alonzo et al., 2002)
Tyrosol p-Hydroxyphenyl ethanol/
4-Hydroxyphenylethanol/ p-HPEA
0.5–14.4 1.7 (Fabiani et al., 2006; Owen et al.,
2000a; Franconi et al., 2006;
Selvaggini et al., 2006; Caravaca
et al., 2005; Salvini et al., 2006;
Carrasco-Pancorbo et al., 2006;
Coni et al., 2000; De Stefano et al.,
1999; Gill et al., 2005;
Gomez-Alonso et al., 2003)
(Continued on next page)
D
o
w
n
lo
ad
ed
 B
y:
 [
De
ak
in
 U
ni
ve
rs
it
y]
 A
t:
 0
3:
22
 1
5 
Ma
rc
h 
20
10
222 S. CICERALE ET AL.
Table 1 Concentrations of the different classes of phenolics present in virgin olive oil. (Continued)
Name of compound Structure
Quantity in extra
virgin and virgin
olive oil (mg/kg)
Quantity in
refined olive
oil (mg/kg) Reference(s)
(3,4-Dihydroxyphenyl)
ethanol-glucoside
NA NA (Carrasco-Pancorbo et al., 2005)
2-(3-4 Dihydroxy phenyl) ethyl
acetate
NA NA (Rios et al., 2005)
2-(4-hydroxyphenyl) ethyl acetate NA NA (Carrasco-Pancorbo et al., 2005)
Secoiridoids
Oleuropein 2.0 NA (Coni et al., 2000)
Dialdehydic form of oleuropein
aglycon
NA NA (Carrasco-Pancorbo et al., 2005)
Dialdehydic form of ligstroside
aglycon
NA NA (Carrasco-Pancorbo et al., 2005)
Ligstroside aglycon 0.8–44.4 NA (Caravaca et al., 2005;
Carrasco-Pancorbo et al., 2006;
Gill et al., 2005; Gomez-Alonzo
et al., 2002)
(Continued on next page)
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Table 1 Concentrations of the different classes of phenolics present in virgin olive oil. (Continued)
Name of compound Structure
Quantity in extra
virgin and virgin
olive oil (mg/kg)
Quantity in
refined olive
oil (mg/kg) Reference(s)
Oleuropein aglycon/3,4-DHPEA-EA 1.8–351.7 NA (Franconi et al., 2006; Selvaggini
et al., 2006; Caravaca et al., 2005;
Salvini et al., 2006; Coni et al.,
2000; De Stefano et al., 1999; Gill
et al., 2005; Gomez-Alonso et al.,
2003; Gomez-Alonzo et al., 2002)
Oleocanthal/Deacetoxy-ligstroside
aglycone/Dialdehydic form of
decarboxy methyl elenolic acid
linked to p-HPEA/p-HPEA-EDA
8.4–298.1 NA (Franconi et al., 2006; Impellizzeri
and Lin, 2006; Selvaggini et al.,
2006; De Stefano et al., 1999; Gill
et al., 2005; Gomez-Alonso et al.,
2003; Gomez-Alonzo et al., 2002)
Dialdehydic form of
decarboxymethyl elenolic acid
linked to 3,4-DHPEA/
3,4-DHPEA-EDA
4.7–522.2 NA (Selvaggini et al., 2006; Salvini et al.,
2006; De Stefano et al., 1999; Gill
et al., 2005; Gomez-Alonso et al.,
2003; Gomez-Alonzo et al., 2002)
Hydroxy-isocromans
1-phenyl-6,7-dihydroxy-isochroman NA NA (Carrasco-Pancorbo et al., 2005)
1-(3′-methoxy-4′-hydroxy)phenyl-
6,7-dihydroxy-isochroman
NA NA (Carrasco-Pancorbo et al., 2005)
(Continued on next page)
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Table 1 Concentrations of the different classes of phenolics present in virgin olive oil. (Continued)
Name of compound Structure
Quantity in extra
virgin and virgin
olive oil (mg/kg)
Quantity in
refined olive
oil (mg/kg) Reference(s)
Flavonoids
Flavones
Apigenin 0.4–2.2 NA (Carrasco-Pancorbo et al., 2006)
Luteolin 0.2–7.6 NA (Franconi et al., 2006;
Carrasco-Pancorbo et al., 2006;
Salvini et al., 2006)
Flavanonol
(+)- Taxifolin NQ, 129.4 NA (Carrasco Pancorbo et al., 2004)
Lignans
(+)-1- Acetoxypinoresinol 0.2–36.2 NA (Selvaggini et al., 2006; Caravaca
et al., 2005; Carrasco-Pancorbo
et al., 2006; Gomez-Alonso et al.,
2003; Gomez-Alonzo et al., 2002)
(+)-1-Hydroxypinoresinol NA NA (Carrasco-Pancorbo et al., 2005)
(+)- Pinoresinol 0.5–34.1 NA (Caravaca et al., 2005;
Carrasco-Pancorbo et al., 2006;
Gomez-Alonso et al., 2003;
Gomez-Alonzo et al., 2002;
Selvaggini et al., 2006)
NA = Not available, NQ = Non quantifiable.
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(Ayton et al., 2007; Gomez-Rico et al., 2006; Romero et al.,
2002; Tovar et al., 2001). In one study the dialdehydic form
of decarboxymethyl elenolic acid linked to hydroxytyrosol de-
creased from 442.8 ± 73.5 mg/kg with minimal irrigation to
183.0 ± 12.2 mg/kg with extensive irrigation (Tovar et al., 2001).
Furthermore, the concentration of the dialdehydic form of decar-
boxymethyl elenolic acid linked to tyrosol and 4-acetoxy-ethyl-
1-1,2-dihydroxybenzene decreased linearly with increased ir-
rigation from 50.9 ± 6.5 mg/kg to 23.1 ± 1.3 mg/kg and
75.9 ± 12.3 mg/kg to 51.8 ± 5.7 mg/kg respectively. Conversely,
the concentration of lignans increased with extensive irrigation
from 168.5 ± 10.7 mg/kg to 228.1 ± 8.0 mg/kg (Tovar et al.,
2001).
Olive Tree Age
The age of olive trees has been postulated to have an influence
on the phenolic concentration in olive oil fruit and the subsequent
oil. Ayton and colleagues (Ayton et al., 2007) demonstrated that
young trees of 4–5 years of age produced olive fruit containing
lower concentrations of phenolics (100–200 mg/kg) compared
to trees of 6–7 years of age which produced olive fruit containing
300–500 mg/kg of phenolic compounds.
Olive Maturation
Maturation of the olive fruit at harvest has also been shown
to affect phenolic composition and concentration in virgin olive
oil. Different concentrations of certain phenolics are present at
differing stages of olive maturity (Brenes et al., 1999; Esti et al.,
1998; Gimeno et al., 2002a; Gomez-Rico et al., 2006; Gutier-
rez et al., 1999; Kalua et al., 2005). For example, the mean
phenolic concentration in virgin olive oil obtained from green
(unripe) olives was 98.38 mg/kg compared to 61.48 mg/kg in
oil obtained from ripe olives (Gimeno et al., 2002a). In gen-
eral, the concentration of hydroxytyrosol and tyrosol increase
as the olive fruit ripens, in parallel with the breakdown of phe-
nolic compounds of higher molecular weight. However, the total
concentration of phenolics in the olive fruit still decreases as the
fruit ripens, due to the degradation of a number of phenolic com-
pounds outweighing the synthesis of new phenolic compounds
(Tripoli et al., 2005).
Processing of Olive Fruit and Oil
The processing of olive fruit to oil has a substantial effect on
concentrations of phenolics in virgin olive oil (Cerretani et al.,
2005; Di Giovacchino et al., 1994; Gimeno et al., 2002a; Kalua
et al., 2006; Mailer and Ayton, 2004; Ranalli et al., 1999; Romero
et al., 2004; Vierhuis et al., 2001). Virgin olive oils extracted
using two-phase centrifugation (a new system for oil extrac-
tion) have been noted to contain a significantly higher phenolic
concentration in comparison to virgin olive oils obtained from
three-phase centrifugation (the traditional method for oil extrac-
tion). De Stefano and colleagues (De Stefano et al., 1999) found
the phenolic concentration of the virgin olive oil obtained from
the two-phase centrifuge to be 673 ± 4 mg/kg for the Coratina
cultivar and 304 ± 5 mg/kg for the Oliarola cultivar and for the
three-phase centrifuge, 585 ± 7 mg/kg for Coratina cultivar, and
263 ± 4 mg/kg for Oliarola cultivar (De Stefano et al., 1999).
Gimeno and colleagues (Gimeno et al., 2002a) also reported
similar advantages in a two-phase extraction with a phenolic
concentration of 123.82 mg/kg for green olives and 80.88 mg/kg
for ripe olives, while the three-phase centrifuge method yielded
a phenolic concentration of 72.93 mg/kg for green olives and
42.07 mg/kg for ripe olives (a 46% decrease in phenolics). This
difference in phenolic concentration is due to the addition of wa-
ter in the three-phase centrifugation method reducing the more
water-soluble phenolics from the oil phase during processing.
Virgin olive oils obtained from the hammer mill process as
opposed to the stone mill have also been noted to contain signif-
icantly higher phenolic contents. A study examining the effect
the hammer mill and stone mill processing methods have on
the phenolic content of the resultant oils found a mean phenolic
concentration of 269 mg/kg for the hammer mill compared to
157 mg/kg for the stone mill (Mailer and Ayton, 2004). More-
over, virgin olive oil obtained from a low-scale mill contains
a higher phenolic content compared to an industrial plant. This
difference is explained by the different conditions of malaxation
(action of slowly churning or mixing milled olives) between the
two methods. In the low-scale mill, malaxation involves lower
temperatures and lower surface contact with the air which results
in a lower oxidation thereby preserving the phenolics present in
virgin olive oil. Also, addition of water to the olive paste before
centrifugation in the industrial plant, is absent in the low-scale
mill, reducing the loss of phenolics in water (Cerretani et al.,
2005).
Furthermore, the extent of processing exerted on the olive
oil has a major influence on phenolic concentration. Ranalli and
colleagues (Ranalli et al., 1999) demonstrated that virgin olive
oil obtained from the first extraction of the olive fruit contained
a higher concentration of total phenolics (99.0 ± 4.0 mg/kg
for Leccino cultivar, 203 ± 8.0 mg/kg for Coratina cultivar and
132 ± 6.0 mg/kg for Dritta cultivar) compared to the virgin olive
oil obtained from the second extraction of the olive fruit (86 ±
5.0 mg/kg for Leccino cultivar, 178 ± 10.0 mg/kg for Coratina
cultivar and 114 ± 9.0 mg/kg for Dritta cultivar). Thus, it is im-
portant to note that the more processing that occurs in olive oil
production, the lower the phenolic concentration contained in
the oil. Using consumer nomenclature, extra virgin olive oil is
obtained from the first cold press or extraction therefore contains
the highest concentration of phenolics, followed by virgin olive
oil from the second pressing. Subsequent extractions (producing
highly refined olive oils) utilize heat and chemicals which sig-
nificantly degrades phenolic compounds (Tripoli et al., 2005).
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Storage of Virgin Olive Oil
The effect of storage conditions on olive oil phenolics has
also been noted in a number of studies (Brenes et al., 2001;
Gutierrez and Fernandez, 2002; Okogeri and Tasioula-Margari,
2002; Rastrelli et al., 2002). Brenes and colleagues (Brenes et al.,
2001) found reductions in total phenolic content of Hojiblanca
and Picual virgin olive oil varieties stored in amber glass jars,
kept in the dark in a thermostatically controlled chamber (30
± 1◦C), ranging from 15–20% of the initial content after one
year of storage. Furthermore, Okogeri and associates (Okogeri
and Tasioula-Margari, 2002) reported reductions of 57–63% in
total phenolics in the Lianolia virgin olive oil variety after six
months of storage in transparent bottles, under diffused light
compared to virgin olive oil stored in transparent bottles sealed
in a carton and stored in the dark. These differences in the loss
of phenolics among the differing varieties may be a result of
initial differences in oil acidity (Brenes et al., 2001). However,
in general, olive oil phenolics appear to degrade during storage.
Application of Heat to Virgin Olive Oil
Many olive oil phenolics are subject to degradation upon
the application of heat during cooking. High temperatures may
result in the alteration of the composition of phenolics in vir-
gin olive oil, or even partial or complete loss (Andrikopoulos
et al., 2002; Brenes et al., 2002; Gomez-Alonso et al., 2003).
For instance, oleuropein aglycon was present at a concentration
of 95.51 ± 7.57 mg/kg before frying at 180◦C for 10 minutes
(one frying operation) and this level was reduced to 8.81 ± 0.58
mg/kg after six frying operations and 5.68 ± 0.02 mg/kg after
12 frying operations (Gomez-Alonso et al., 2003). Andrikopou-
los and colleagues (Andrikopoulos et al., 2002) also noted that
the retention of total phenolics in a virgin olive oil ranged from
70–80% after the first frying operation (175 ± 5◦C, 6 min) to
20–30% after the eighth frying operation. Conversely, a study by
Pellegrini et al. (Pellegrini et al., 2001) demonstrated that pheno-
lics in virgin olive oil reduced the loss of antioxidant activity in
the oil during heating conditions ranging from 160–190◦C and
30–120 min. Due to the small number of studies conducted and
varied results obtained from studies investigating the thermal
degradation of olive oil phenolics, further research is required.
Analytical Method used to Quantify Phenolics in Virgin
Olive Oil
Finally, the analytical method used to quantify the level of
phenolics present in virgin olive oil has an influence on the re-
ported concentration (Carrasco-Pancorbo et al., 2005). Accord-
ing to Visioli et al. (2002) a major problem with the qualitative
and quantitative evaluation of phenolics in virgin olive oil is
the current lack of appropriate methodology. Furthermore, the
inaccuracy of the two main methods for olive oil phenolic quan-
tification, Folin-Ciocalteau reagent and high performance liquid
chromatography (HPLC), may be a source of this discrepancy
(Baccouri et al., 2007). Whilst the Folin-Ciocalteau method is
economical, a limitation to this method is its low specificity and
inability to provide qualitative information on any individual
olive oil phenolic. Furthermore, although HPLC is sensitive and
specific it can be time consuming, and unless it is accompanied
by standards and/or a qualitative method such as mass spectrom-
etry (MS) it cannot provide quantitative and qualitative informa-
tion on phenolic compounds present in virgin olive oil (Tripoli
et al., 2005; Visioli et al., 2002). Therefore, methods to accu-
rately and reproducibly determine phenolics in virgin olive oils
are urgently required in order for this area of research to advance.
BIOAVAILABITY OF OLIVE OIL PHENOLICS
Information on the absorption and disposition of olive oil
phenolic compounds is essential in determining their potential
in exerting healthful affects in vivo (Tripoli et al., 2005). The
majority of studies conducted in this area have focused on hy-
droxytyrosol, tyrosol, and oleuropein.
Phenolic compounds from virgin olive oil have been demon-
strated to be highly bioavailable. Hydroxytyrosol and tyrosol
are absorbed after ingestion in a dose-dependent nature (Caruso
et al., 2001; Visioli et al., 2000b; Visioli et al., 2000c). Further-
more, Tuck, and colleagues (Tuck et al., 2001) demonstrated
the increased bioavailability of hydroxytyrosol and tyrosol when
administered as an olive oil solution compared to an aqueous so-
lution. The authors suggested that antioxidants present in virgin
olive oil may have prevented the breakdown of the phenolics in
the gastrointestinal tract prior to absorption (Tuck et al., 2001).
Vissers and colleagues (Vissers et al., 2002) found that absorp-
tion of administered ligstroside-aglycone, hydroxytyrosol, ty-
rosol, and oleuropein-aglycone was 55–66% in human subjects.
The amount of excreted phenolics (mainly in the form of hy-
droxytyrosol and tyrosol) was determined to be 5–16% of the
total ingested, thus, only a small fraction of the ingested olive oil
phenolics were recovered in urine. Miro Casas and associates
(Miro Casas et al., 2001) demonstrated a mean urinary recovery
of 24.7 ± 8.5% of administered tyrosol in eight healthy subjects.
Visioli and colleagues (Visioli et al., 2000b) reported the excre-
tion of administered hydroxytyrosol to range from 30–60% and
20–22% for tyrosol in six healthy human subjects. These figures
indicate that humans absorb a major part of the dietary olive oil
phenolics they consume (Vissers et al., 2002). Further studies
are required, however, to determine olive oil phenolic excretion
through other bodily functions including feces.
The metabolism of olive oil phenolics is also an impor-
tant point of investigation in regards to understanding their
bioavailability. Vissers and colleagues (Vissers et al., 2002)
have suggested that an important step in the metabolism of
the olive oil phenolics oleuropein-glycoside and oleuropein and
ligstroside-aglycones is their formation into hydroxytyrosol or
tyrosol. This was supported by their finding that 15% of a
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oleuropein-glycoside supplement administered to healthy hu-
man subjects was excreted in urine as hydroxytyrosol and ty-
rosol (Vissers et al., 2002). Another key step in olive oil phe-
nolic metabolism may be the conjugation to glucuronic acid. A
number of studies have found hydroxytyrosol and tyrosol to be
excreted in urine as glucuronides (Caruso et al., 2001; Visioli
et al., 2001; Visioli et al., 2000b; Vissers et al., 2002). Fur-
thermore, the mechanism of absorption of olive oil phenolics
remains unclear. However, the different polarities of the various
phenolics has been suggested to play a role in the absorption of
these compounds (Vissers et al., 2002).
OLIVE OIL PHENOLICS AND HEALTH
Experimental evidence obtained from human and animal
studies (both in vivo and in vitro) demonstrate that olive oil
phenolics have biological activities which may be important in
the reduction in risk and severity of certain chronic diseases. Fig-
ure 1 demonstrates the biological activities exerted by olive oil
phenolics. Table 2 lists the findings of several human studies that
have demonstrated the biological effects of olive oil phenolics.
Effects on Plasma Lipoproteins
There is supporting evidence for the association between el-
evated, low density lipoprotein cholesterol (LDL-C) levels, and
increased risk of cardiovascular events, as well as the protective
effect of high density lipoprotein cholesterol (HDL-C) concen-
trations (Chrysohoou et al., 2006; Gordon et al., 1981; Ulbricht
and Southgate, 1991). Olive oil phenolics have been found to
favorably alter the proportion of LDL-C and HDL-C in humans.
Data from a controlled human study containing 200 healthy male
subjects, demonstrated that total cholesterol (TC) to HDL-C ra-
tio decreased linearly with the phenolic content of the olive oil
(Covas et al., 2006b). The authors also noted a dose-dependent
increase in HDL-C. An increase ranging from 5.1% to 6.7%
in HDL-C by phenol-rich virgin olive oils has also been noted
in two additional human studies (Marrugat et al., 2004; Wein-
brenner et al., 2004). Furthermore, in one human study, the con-
sumption of virgin olive oil rich in phenolics led to a significant
decrease in LDL-C after one week of consumption (Gimeno
et al., 2002b). However, it must be noted that three human stud-
ies did not observe an olive oil phenolic lipid altering effect
(Ramirez-Tortosa et al., 1999; Visioli et al., 2005; Vissers et al.,
2001). These results may be due to the use of people with mild
Figure 1 Biological activities of olive oil phenolics.
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Table 2 Randomized, crossover, controlled, human studies on the effect of olive oil phenolic compounds on blood lipids, oxidation, inflammation, and damage
[adapted from Covas et al., 2007 (Covas, 2007)].
Treatment Subjects
Concentration of
phenols Study design Oxidative marker Findings Reference
Phenol-rich vs.
phenol-poor olive
oil vs. corn oil
12 healthy
subjects
607 vs. 16 vs. 0
mg/kg
Acute dose,
crossover
Plasma TXB2 Decrease in TXB2 and LTB4
with increasing phenolic
content of olive oil and
concomitant increase in
plasma antioxidant capacity
with increased phenolic
content of olive oil.
(Bogani et al.,
2007)Plasma LTB4
Plasma antioxidant
capacity
Phenol-rich vs.
phenol poor olive
oil
14 healthy
subjects
303 vs. 0.3 mg/kg 4 week,
crossover
Plasma oxLDL Increase in plasma antioxidant
capacity but no change in
oxLDL.
(Bonanome
et al., 2000)Serum antioxidant
capacity
Phenol-rich vs.
phenol-moderate
vs. phenol-poor
olive oil
12 healthy
subjects
366 vs. 164 vs. 2.7
mg/kg
Acute dose,
crossover
Plasma
F2-isoprostanes
All olive oils promoted
postprandial oxidative stress
indicated by increased
F2-isoprostanes, however,
the degree of LDL oxidation
decreased as the phenolic
content in administered oil
increased.
(Covas et al.,
2006a)
Plasma oxLDL
Phenol-rich vs.
phenol-moderate
vs. phenol-poor
olive oil
200 healthy
subjects
366 vs. 164 vs. 2.7
mg/kg
3 week,
crossover
A linear increase in HDL-C
was observed for low-,
medium-, and high phenolic
olive oil. Furthermore, TC to
HDL-C ratio decreased
linearly with the increasing
phenolic content of the olive
oil. OxLDL decreased
linearly with increasing
phenolic content of and TG
levels decreased for all olive
oils. Oxidative stress markers
indicated by GSH and GSSG
decreased linearly with
increasing phenolic content.
(Covas et al.,
2006b)
Plasma oxLDL
Plasma lipids
plasma F2-
isoprostanes
GSH
GSSG
Phenol-rich vs.
phenol poor olive
oil
43 coronary
heart
disease
subjects
161 vs. 14.7
mg/kg
3 week,
crossover
Plasma oxLDL Decrease in oxLDL and LPO
and increase in GSH-Px
upon phenol-rich olive oil
consumption.
(Fito et al.,
2005)Plasma LPO
Whole blood GSH-Px
Phenol-rich vs.
phenol poor olive
oil
28 stable
coronary
heart
disease
subjects
161 vs. 14.7
mg/kg
3 week,
crossover
IL-6 Decrease in IL-6 and CRP after
consumption of the
phenol-rich olive oil. No
change observed in sICAM-1
and sVCAM-1.
(Fito et al.,
2007)sICAM-1
sVCAM-1
CRP
Phenol-rich vs.
phenol-moderate
vs. phenol-poor
olive oil
30 healthy
subjects
150 vs. 68 vs. 0
mg/kg
3 week,
crossover
Plasma lipids Sustained consumption of
phenol-rich olive oil was
more effective in protecting
LDL from oxidation and in
raising HDL cholesterol than
olive oils with lesser
quantities of phenolics.
(Marrugat et al.,
2004)OxLDL
Phenol-rich vs.
phenol poor olive
oil
25 healthy
subjects
308 vs. 43 mg/kg 3 week,
crossover
Plasma antioxidant
capacity
Plasma antioxidant capacity
and oxLDL did not differ
significantly between the
phenol-rich and phenol-poor
olive oil.
(Moschandreas
et al., 2002)
OxLDL
Phenol-rich vs.
phenol-poor olive
oil
24 peripheral
vascular
disease
subjects
800 vs. 60 mg/kg 12 week,
crossover
Plasma lipids A lower oxLDL was noted in
subjects after administration
of phenol-rich olive oil. No
difference in plasma lipids
was observed.
(Ramirez-
Tortosa et al.,
1999)
Plasma oxLDL
(Continued on next page)
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Table 2 Randomized, crossover, controlled, human studies on the effect of olive oil phenolic compounds on blood lipids, oxidation, inflammation, and damage
[adapted from Covas et al., 2007 (Covas, 2007)]. (Continued)
Treatment Subjects
Concentration of
phenols Study design Oxidative marker Findings Reference
Phenol-rich vs.
phenol-poor
breakfast
21 hyperc-
holes-
terolemic
subjects
400 vs. 80 mg/kg Acute dose,
crossover
Plasma LPO Decrease in LPO and
F2-isoprostanes with intake
of the high phenol-enriched
breakfast compared to low
phenol-enriched breakfast.
(Ruano et al.,
2005)plasma
F2-isoprostanes
Phenol-rich vs.
phenol poor olive
oil
10 healthy
subjects
592 vs. 147 mg/kg 8 week,
crossover
Oxidative DNA
damage
A reduction in DNA damage
with the consumption of a
phenol-rich olive oil diet
was demonstrated. No
difference was seen in
plasma antioxidant
capacity.
(Salvini et al.,
2006)
Plasma antioxidant
capacity
Olive oil with
differing amounts
of phenolics
6 healthy
subjects
1950 vs. Acute dose,
cross over
Urinary
F2-isoprostanes
A dose-dependent decrease in
urinary excretion of
F2-isoprostanes was noted
upon administration of
phenol-rich olive oil.
(Visioli et al.,
2000a)1462.5 vs.
975 vs.
487.5 mg/kg
Phenol-rich vs.
phenol-poor olive
oil
22 mild dys-
lipidemic
subjects
166 vs. 2 mg/kg 7 week,
crossover
Plasma lipids Plasma TXB2decreased with
phenol-rich olive oil
supplementation. Plasma
antioxidant capacity
increased after phenol-rich
olive oil administration. No
effect on urinary
F2-isoprostanes and plasma
lipids between phenol-rich
and phenol-poor olive oil
were observed.
(Visioli et al.,
2005)Plasma TXB2
Plasma antioxidant
capacity
Urinary
F2-isoprostanes
Phenol-rich vs.
phenol poor olive
oil
46 health
subjects
308 vs. 43 mg/kg 3 week,
crossover
Plasma lipids No effect on plasma lipids,
oxLDL, and LPO were
noted between the
phenol-rich and
phenol-poor olive oils.
(Vissers et al.,
2001)Plasma oxLDL
Plasma LPO
Phenol-rich vs.
phenol-moderate
vs. phenol-poor
olive oil
12 healthy
subjects
486 vs. 133 vs. 10
mg/kg
4 day, crossover Plasma lipids Short-term consumption of
phenol-rich olive oil
decreased plasma oxLDL,
urinary 8-oxo-dG, and
increased plasma HDL-C
and GSH-Px, in a
dose-dependent manner
with the increasing
phenolic content of the
olive oil administered.
(Weinbrenner
et al., 2004)Plasma oxLDL
Plasma GSH-Px
Urinary 8-oxo-dG
dyslipidemia and peripheral vascular disease in two of the three
studies and in the third study, the use of a three week study period
may not have been long enough to observe a treatment effect.
Animal studies have also demonstrated that olive oil phe-
nolics possess beneficial lipid modulating abilities. A study
conducted in rats noted that virgin olive oil rich in phenolics,
decreased TC, LDL-C, and triglyceride (TG) concentrations
(Gorinstein et al., 2002). Another study in rats found a statis-
tically significant influence of virgin olive oil rich in phenolics
on HDL-C levels, in that, HDL-C increased considerably after
the ingestion of the virgin olive oil compared to that of olive
oil and sunflower oil (both containing non-detectable levels of
phenolics) (Mangas-Cruz et al., 2001). Furthermore, a study in
rabbits, found an increase in HDL-C and reduction in TC and
TG upon phenol-rich virgin olive oil consumption (Gonzalez-
Santiago et al., 2006).
The lipid modulating abilities of olive oil phenolics may
in part explain the low incidence of atherosclerosis and CVD
among Mediterranean populations despite their high lipid in-
take (usually in excess of 30% of total energy intake) (Kushi
et al., 1995; Stark and Madar, 2002).
Effects on LDL Oxidation
LDL oxidation (oxLDL) is considered a hallmark for
atherosclerosis and CVD development (Witztum, 1994).
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Oxidatively modified LDL represents a source of damage to the
vascular wall and this stimulates macrophage uptake and forma-
tion of foam cells. The foam cells form fatty streaks which are
involved in plaque formation (Coni et al., 2000; Fito et al., 2005;
Patrick and Uzick, 2001; Vissers et al., 2001). Several human
and animal studies have demonstrated that the degree of oxLDL
in vivo, decreases as the phenolic content in the administered
olive oil increases (Covas et al., 2006a; Covas et al., 2006b; Fito
et al., 2005; Gimeno et al., 2002b; Marrugat et al., 2004; Nico-
laiew et al., 1998; Ramirez-Tortosa et al., 1999; Weinbrenner
et al., 2004). However, three human studies have demonstrated
that phenol-rich virgin olive oil does not lower oxLDL. This
may have been due to the study period possibly being not long
enough in these studies (Bonanome et al., 2000; Moschandreas
et al., 2002; Vissers et al., 2001).
A number of in vitro studies also mirror these positive find-
ings (Berrougui et al., 2006; Franconi et al., 2006; Masella et al.,
2004; Visioli et al., 1995). Therefore, olive oil phenolics have
been regarded as being anti-atherogenic due to their oxLDL low-
ering effect. This possible anti-atherogenic property of olive oil
phenolics may therefore partially explain the lower atheroscle-
rosis and CVD risk and incidence among Mediterranean
populations.
Effect on Oxidative Damage to DNA
Oxidative DNA damage is considered to be a crucial step in
human carcinogenesis (Cooke et al., 2003). Mammalian cells
are continuously attacked by oxygen radicals and such dam-
age, if not appropriately attenuated, contributes to the genera-
tion of DNA damage and mutations that could direct the cell to
a cancerous formation (Salvini et al., 2006). The major DNA
modification appears to be the hydroxylation of guanine in the
8-position to 8oxodG, therefore urinary excretion of 8oxodG
has been used as a biomarker of oxidative stress in DNA (Cooke
et al., 2003; Machowetz et al., 2007). Data from a controlled
human intervention trial demonstrated that the consumption of
virgin olive oil containing phenolics significantly reduced DNA
oxidation measured by 8oxodG (Machowetz et al., 2007). Since
a reduction of DNA oxidative damage is a mechanism underly-
ing possible cancer prevention, this finding may explain some
of the differences in cancer incidence between Mediterranean
populations and other populations in the world.
Effect on other Markers of Oxidation
Markers such as F2-isoprostanes, lipid peroxides (LPO), and
gluthathione including oxidized gluthathione (GSSG), reduced
glutathione (GSH) and glutathione peroxidase (GSH-Px) are
used as indicators of oxidative stress. F2-isoprostanes are derived
from the free radical oxidation of the cell membrane derived
polyunsaturated fatty acid (FA), arachidonic acid. LPO is likely
to be derived from oxidation of FA (Ruano et al., 2005). Fur-
thermore, the main biological role of gluthathione is protecting
an organism from oxidative damage. In particular, depletion of
GSH precedes lipid oxidation and atherogenesis in vivo (Biswas
et al., 2005).
A number of human studies have demonstrated the beneficial
effects of olive oil phenolics on these aforementioned markers
of oxidative stress. A randomized cross over study found the
intake of a olive oil phenolic-enriched breakfast was associ-
ated with a significantly lower increase in F2-isoprostane levels
compared to a low olive oil phenolic-enriched breakfast (Ru-
ano et al., 2005). Additionally, Visioli et al. (2000a) demon-
strated that the consumption of a phenolic-rich virgin olive oil
was dose-dependently associated with a significant decrease in
urinary excretion of F2-isoprostanes. One human study did not
find an effect of olive oil phenolics on F2-isoprostane levels,
and the authors suggested that the relatively limited duration of
the study may have masked a possible treatment effect (Visioli
et al., 2005). An animal study also found that administration
of olive mill waste water (OMWW) containing hydroxytyrosol,
to rats exposed to passive cigarette smoke, significantly low-
ered F2-isoprostane levels (P < 0.05) (Visioli et al., 2000c). The
authors concluded that hydroxytyrosol present in OMWW was
effective in decreasing the oxidative stress associated with pas-
sive cigarette smoke. Furthermore, Covas and colleagues (Covas
et al., 2006b) found phenol-rich virgin olive oil improved the
balance between GSH and GSSG, while Weinbrenner and col-
leagues (Weinbrenner et al., 2004) found an increase in GSH-Px
after phenol-rich virgin olive oil administration in human sub-
jects. Additionally, Ruano et al. (2005) found a decrease in LPO
after olive oil phenolic administration.
Several in vivo and in vitro studies also demonstrate the ben-
eficial effects of olive oil phenolics on the oxidative stress mark-
ers, reactive oxygen species (ROS), and total plasma antioxidant
capacity. ROS are formed as a natural byproduct of the normal
metabolism of oxygen and play an important role in cell signal-
ing. However, during times of environmental stress, ROS levels
can increase dramatically, which can result in significant damage
to cell structures resulting in oxidative stress. Total antioxidant
capacity refers to a full spectrum of antioxidant activity against
various reactive oxygen/nitrogen radicals. Increased ROS and
decreased plasma antioxidant capacity have been suggested to be
involved in the development of a number of chronic diseases in-
cluding, atherosclerosis, CVD, certain cancers, and Alzheimer’s
disease (Reinisch et al., 1998).
A study involving the treatment of human hepatoma HepG2
cells with hydroxytyrosol, demonstrated a reduced generation of
ROS (Goya et al., 2007). Another study noted the ability of olive
oil phenolics to scavenge ROS and nitrogen species under chem-
ically simulated conditions of oxidative stress (de la Puerta et al.,
2001). Owen and colleagues (Owen et al., 2000a) also obtained
data demonstrating that olive oil phenolics scavenge ROS gen-
erated from human fecal material. Additionally, another in vitro
study, found that tyrosol modulated ROS and nitrogen oxide pro-
duction in murine macrophages (Moreno, 2003). Furthermore,
total plasma antioxidant capacity has been shown to increase
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after administration of phenol-rich virgin olive oils in both hu-
mans (Bogani et al., 2007; Salvini et al., 2006; Visioli et al.,
2005) and animals (Gorinstein et al., 2002). Contrary to this,
one study did not show an increase in total plasma antioxidant
capacity. This may have been a result of period effects and inter-
actions between diet and administration period (Moschandreas
et al., 2002).
The antioxidant capacity of olive oil phenolics may partially
explain the differences in chronic disease (in particularly CVD
and cancer incidence) between Mediterranean populations con-
suming significant amounts of virgin olive oil and those popu-
lations who do not have as high a virgin olive oil consumption.
Effects on Markers of Inflammation
The anti-inflammatory effects of olive oil phenolics in hu-
mans have been demonstrated, in that, administration of phenol-
rich virgin olive oil or particular olive oil phenolics decreases
plasma thromboxane B2(TXB2) and leukotriene B4 (LTB4) (Bo-
gani et al., 2007; Leger et al., 2005; Visioli et al., 2005; Wein-
brenner et al., 2004). Both TXB2 and LTB4 have proinflam-
matory effects, in that, TXB2 has the ability to increase blood
platelet aggregation and LTB4 has a chemotactic effect on mi-
grating neutrophils, aiding the necessary cells to areas of dam-
aged tissue (Bogani et al., 2007; Groff and Gropper, 2000;
Samuelsson, 1983). These compounds result in the produc-
tion of pain, swelling, redness, and heat associated with in-
flammation (Tiziani, 2006). Furthermore, another human study
found that consumption of phenol-rich virgin olive oil decreased
interleukin-6 (IL-6) and C-reactive protein (CRP) concentra-
tions. IL-6 is a pro-inflammatory cytokine secreted to stimulate
an immune response to trauma which in turn leads to inflam-
mation. Furthermore, the levels of CRP rise dramatically upon
inflammation in the body (Fito et al., 2007).
However, one animal study by Acin et al. (2006) demon-
strated that the administration of 10 mg/kg/day hydroxytyrosol
to mice had a pro-inflammatory effect in that the compound in-
creased atherosclerotic lesion areas and circulating monocytes
expressing Mac-1, which is involved in the recruitment of mono-
cytes in inflammation related to atherosclerosis development.
The authors of this study concluded that olive oil phenolic-
enriched products, out of the original matrix, are possibly harm-
ful to health (Acin et al., 2006).
In vitro studies also support the findings from human in-
flammation studies. Olive oil phenolics have been found to
decrease arachidonic acid release and arachidonic acid metabo-
lite synthesis in vitro and both are involved in the inflamma-
tory process (Moreno, 2003). Specifically, oleocanthal has been
shown to mimic pharmacological properties of the non-steroidal
anti-inflammatory drug, ibuprofen that inhibits cyclooxygenase-
1 (COX-1) and cyclooxygenase-2 (COX-2) activity (both are in-
volved in the inflammatory process) (Beauchamp et al., 2005).
Stimulation of the COX enzymes results in the conversion of
arachidonate to the eicosanoids, prostaglandins and thrombox-
ane, resulting in inflammation (Brody, 1999; Groff and Gropper,
2000).
The findings from these aforementioned in vivo and in vitro
studies are most important as they demonstrate that olive oil phe-
nolics have the ability to decrease inflammatory processes that
have been implicated in the development of various chronic dis-
eases with an inflammatory component, including CVD and cer-
tain types of cancers (Ferrucci et al., 2005). The ability of olive
oil phenolics to attenuate inflammatory processes may partly ex-
plain the lowered risk rates for these particular diseases among
Mediterranean populations.
Effects on Platelet Function
Blood platelets play a major role in CVD and atherosclerosis,
in that, chronic and recurrent damage to the vascular epithelium
results in the development of lesions. These lesions then stimu-
late endothelial adhesion molecule expression, platelet activity,
and aggregation (De La Cruz et al., 2000; White, 1994). Circu-
lating monocytes are attracted by these molecules and adhere to
the endothelium and differentiate into macrophages, which scav-
enge oxLDL and TG-rich lipoproteins, becoming foam cells and
forming fatty streaks (Perona et al., 2006).
Olive oil phenolics at nutritionally relevant concentrations
have inhibited endothelial adhesion molecule expression upon
incubation with human umbilical vein endothelial cells (Carluc-
cio et al., 2003). They also inhibit human platelet activity in vitro
(Togna et al., 2003). Furthermore, hydroxytyrosol was noted to
completely inhibit platelet aggregation in the range of 100–400
µM (Petroni et al., 1995). These findings may partly explain the
lowered CVD and atherosclerosis incidence between Mediter-
ranean populations compared with other populations worldwide.
Effects on Cellular Function
Although cancer development involves a number of pro-
cesses, in almost all instances deregulated cell proliferation and
suppressed cell death provide the underlying basis for tumor
progression (Evan and Vousden, 2001). A number of in vitro
studies have shown that olive oil phenolics have beneficial ef-
fects on cellular function (Fabiani et al., 2006; Gill et al., 2005;
Manna et al., 1997; Menendez et al., 2007). In human promyelo-
cytic HL60 leukemia cells, an olive oil phenolic extract inhibited
cell proliferation in a time- and concentration-dependent man-
ner. Cell growth was completely blocked at a phenolic extract
concentration of 13.5 mg/kg and apoptosis was also induced
(Fabiani et al., 2006). In another study involving MCF-7 and
SKBR3 breast cancer cells, oleuropein aglycone was found to
dose-dependently inhibit growth in these cell lines and reduce
expression of the HER2 oncogene which plays a role in malig-
nant transformation, tumorigenesis, and metastasis (Menendez
et al., 2007). Olive oil phenolics have also been found to im-
prove cell integrity and viability in CaCo2 cells (Gill et al., 2005;
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Manna et al., 1997). Such a physiological mode of action may
explain the differences that exist in cancer incidence between
Mediterranean populations and other populations world-wide.
Effects on Microbial Activity
Olive oil phenolics have been found to contain antimicrobial
properties in vitro (Medina et al., 2006). Medina and colleagues
(Medina et al., 2006) revealed that virgin olive oils containing the
dialdehydic form of decarboxymethyl oleuropein and ligstroside
aglycons, hydroxytyrosol, and tyrosol, had strong bactericidal
action against a broad spectrum of micro-organisms. The de-
struction of microorganisms indicates that olive oil phenolics
may be useful therapeutic agents in the treatment of some infec-
tious diseases (Tripoli et al., 2005).
PHENOLICS FROM OLIVE OIL MILL WASTE WATER
AND HEALTH
As a result of olive oil production, a large quantity of OMWW
is generated and discarded (Visioli et al., 1999). OMWW is con-
sidered a pollutant due to its acidic nature and high content of
organic molecules, particularly phenolic mixtures (Fiorentino
et al., 2003). Phenolics in OMWW pose a particular problem
as they have been characterized by a high chemical oxygen de-
mand (COD) (Ranalli et al., 2003). Phenolics have also been
demonstrated to be highly phytotoxic (Cappasso et al., 1992),
toxic against aquatic organisms (Fiorentino et al., 2003), and
difficult to decompose (Obied et al., 2005).
Although, OMWW poses a threat to the environment, the
phenolic nature of this by-product has warranted further inves-
tigation as being a source of bioactive molecules (Obied et al.,
2005). Thus, there is considerable current interest in extracting
phenolics from OMWW for nutritional and pharmaceutical pur-
poses and at the same time reducing the organic load of this
olive oil by-product that is a major threat to the environment. To
date, a small number of in vivo and in vitro studies have demon-
strated the health benefiting capacity of olive oil phenolics from
OMWW (Leger et al., 2005; Medina et al., 2002; Schaffer et al.,
2007; Visioli et al., 2000c; Visioli et al., 1999).
CONCLUSION
It has been postulated for decades that the consumption of
virgin olive oil has beneficial effects on health and this may
contribute to the low chronic disease risk observed in Mediter-
ranean populations where virgin olive oil consumption is high.
However, only in the past decade have the biological properties
of virgin olive oil’s constituents (particularly olive oil phenolics)
been investigated. Olive oil phenolics have been demonstrated
to possess beneficial biological activities such as altered lipid
composition, platelet and cellular function and microbial activ-
ity, as well as a reduction in oxidative damage and inflammation
in both human and animal (in vivo, in vitro) studies. Olive oil
phenolics are also highly bioavailable; however, the metabolism
of olive oil phenolics in humans still requires further research.
Furthermore, a number of horticultural and processing factors
that have the ability to affect phenolic concentrations in virgin
olive oil have been identified. Maximizing the concentration and
quality of phenolics in virgin olive oils is important in maximiz-
ing the myriad health benefits of virgin olive oil.
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